Sunshine Biopharma (SBFMW) EPS (Weighted Average and Diluted) Growth (1y) (2022 - 2025)
Sunshine Biopharma (SBFMW) EPS (Weighted Average and Diluted) Growth (1y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 72.22% |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 5.97% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -12.22% |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 2,287.50% |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | -471.99% |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | -15.38% |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -407.69% |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 76.47% |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 215.56% |
| 10 | Sunshine Biopharma | - | - | 2.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 78.00% |
| Dec 31, 2024 | 96.84% |
| Mar 31, 2024 | 74.13% |
| Dec 31, 2023 | -6,193.06% |
| Sep 30, 2023 | 67.13% |
| Jun 30, 2023 | 36.00% |
| Mar 31, 2023 | -3,197.04% |
| Dec 31, 2022 | -706.43% |